NCT Number: NCT01549444
Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension
The purpose of this study is to find out if mothers with high blood pressure (Hypertension) and/or diabetes have babies with high levels of different substances (that help to regulate blood pressure, called Renin and Aldosterone) in their blood. The investigators are also trying to determine if these babies have higher blood pressure than those babies born to mothers without high blood pressure or diabetes, during the first year of life.
The investigators will measure your baby's blood pressure once a day for the first 4 days, at 1 week of age, and then once per week until your baby is discharged. The investigators will also measure the blood pressure after discharge at 4 and 10 months of age, either on the day of your baby's follow-up appointment in the Neonatal Follow-up Clinic or at a visit to our Outpatient Nephrology Clinic, both at CHEO.
Looking for future studies?
Notify MeKey information
Conditions
Age range
26 week–34 week
Sex eligibility
All sexes
Study type
Observational
Primary location
Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
About this study
We will compare two groups of babies born between 26+0 and 34+0 weeks gestation.Group 1 is the babies born to mothers with diabetes and/or high blood pressure, and babies that are small for dates. Group 2 are babies that are 26 to 34 weeks of age, that are born to mothers without these problems.
In the study we will measure the baby's blood pressure once a day for the first 4 days, at 1 week of age, and then once per week until the baby is discharged. We will also measure the blood pressure after discharge at 4 and 10 months of age, either on the day of your baby's follow-up appointment in the Neonatal Follow-up Clinic or at a visit to our Outpatient Nephrology Clinic, both at CHEO.
As blood tests will be done. A small amount of extra blood, 0.75ml - 1.5 ml (about 1/6 -1/3 of a teaspoon, or approximately 1 ml) will be collected for measurement of the blood substances we are studying will be collected when the baby has their regular non-study blood work.
This will be done within six hours of birth and then again at 2-3 weeks of life.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Infants < 6 hours of age who require NICU admission
- Infants 26+0 to 34+0 weeks gestation.
Exclusion criteria
- Immediate Exclusion from Enrollment
- Maternal treatment with drugs known to be teratogenic and cause nephrotoxicity in the fetus (i.e. ACE-Inhibitor).
- Infants with known congenital anomalies and/or renal anomalies.
- Infants with known chromosomal anomalies.
- Infants with severe asphyxia defined as cord pH < 7.0, 5 min Apgar < 3, and urine positive for blood.
- Infants with a known or suspected blood loss at birth (ie: uterine rupture, placental abruption, bleeding placenta previa, or post-natal blood loss in the delivery room).
- Infants who will not receive follow-up care in Ottawa upon discharge from the NICU (ie: live out of town).
Treatment and study plan
Primary outcomes
-
Renin and Aldosterone levels corelated to BP measurements
Time frame: at birth and at 2-3 weeks of age
We hypothesize that infants with higher levels of RE and ALDO at birth and in the early neonatal period will have a higher BP during the first year of life.
Secondary outcomes
-
Blood pressure measurements
Time frame: in the first month of life, then at 4 and10 months of age
We hypothesize that premature infants of mothers with hypertension (HT) and/or diabetes, or who are significantly growth restricted will have a higher blood pressure (BP) in the first year of life.
Sponsors and collaborators
Lead sponsor
Ottawa Hospital Research Institute
Other
Collaborators
- Australian National University
- The Physicians' Services Incorporated Foundation
Registry information
Official study title
Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension (RENAL HIT Study)
Important dates
- Study start
- 2012
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Mar 9, 2012
- Registry last updated
- Oct 22, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Genetics of Type 2 Diabetes in West Africans
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsSupporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension
NCT05565716
Cardiovascular Diseases, Chronic Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsRisk Factors, Costs, and Impacts of ED Boarding
NCT07532564
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsDietary Approaches to Stop Hypertension for Diabetes
NCT04286555
Cardiovascular Diseases, Diabetes
Baltimore, Maryland, United States
View Trial Details